Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Abnormal glucose levels common in ‘nondiabetic’ PCI patients, tied to worse outcomes

Roughly one-third of patients without known diabetes in a PCI trial had abnormal glucose readings and demonstrated up to a four-fold risk of adverse outcomes within one year, researchers reported in JACC: Cardiovascular Interventions.

Washington Post details history, improvement of CABG procedures

In the half-century since the first coronary artery bypass surgery was performed, the procedure has grown in popularity and safety. The Washington Post highlighted the history of the procedure and its place in cardiology.

Thumbnail

Medtronic’s 2 mm DES gains FDA approval, becomes smallest on market

The FDA has approved Medtronic's two-millimeter Resolute Onyx drug-eluting stent (DES), making it the smallest DES on the U.S. market.

Thumbnail

ACC honors transplant recipient as part of CardioSmart program

The American College of Cardiology has recognized Melissa Cappuccilli, a nurse and single mother of four who received a heart transplant in 2013, as a part of its “I am CardioSmart” contest.

CABG tops PCI for those with diabetes, heart disease and left ventricular dysfunction

Coronary artery bypass grafting (CABG) is preferred to percutaneous coronary intervention for patients with diabetes and coronary artery disease (CAD). But new research showed CABG outperformed PCI when focusing specifically on individuals with left ventricular dysfunction (LVD), a population that had been excluded in past studies.

European experts release guidelines about high-altitude exposure for cardiovascular patients

A group of prominent European medical societies published clinical recommendations for those with pre-existing cardiovascular conditions at high altitude. The document was published Jan. 11 in the European Heart Journal.

Post-operative AFib common in CABG, linked to future stroke, death

New-onset atrial fibrillation (NOAF) occurred in 18 percent of patients undergoing coronary artery bypass grafting (CABG) but just 0.1 percent of those receiving PCI, according to an analysis of the international EXCEL trial published in the Journal of the American College of Cardiology. What’s more, the patients who developed NOAF within a few days of surgery were at a 3.02-fold risk of death and a 4.19-fold risk of suffering a stroke over the following three years.

Thumbnail

FDA expands Impella heart pumps’ indication for high-risk PCI

A day after announcing the FDA’s expanded approval for cardiogenic shock associated with cardiomyopathy, device manufacturer Abiomed said its Impella 2.5 and Impella CP pumps are now indicated for temporary ventricular support during high-risk percutaneous coronary intervention (PCI) regardless of a patient’s ejection fraction.

Displaying 969 - 976 of 2683

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.